Treatment of Newly Diagnosed Patients Eith Acutypromyelocytic Leukemia, Aged > 12 Months (1 Year) and <75 Years, Using All-trans Retinoic Acid in Combination With Idarubicin
Inclusion Criteria:
- Age > 12 months (1 year) and < 75 years
- Morphological newly diagnosis of APL
- Presence of the PML-RARa transcript
- No cardiac contraindications to anthracycline chemotherapy
- Serum creatinine <=2.5 mg/dL
- Serum alkaline phosphatase <= 3 times the normal upper limit
- Serum bilirubin <= 3 times the normal upper limit
- Serum SGOT <= 3 times the upper normal limit
- Negative pregnancy test
- Informed consent
Exclusion Criteria:
- Age <= 12 months and >=75 years
- absence of the PML-RARa transcript
- Preganant of lactating women
- Presence of active serious infections that are not controlled by antibiotics
- Prior treatment with antileukemic therapy (excluded corticosteroids)
- Presence of severe concomitant psychiatric disease
- Presence of other concomitant malignant tumors, except basal cell carcinoma
- Concurrent treatment with cytotoxic chemotherapy or radiotherapy
- Cardiac contraindications to anthracycline chemotherapy
- Serum creatinine >2.5 mg/dL
- Serum alkaline phosphatase > 3 times the normal upper limit
- Serum bilirubin > 3 times the normal upper limit
- Serum SGOT > 3 times the upper normal limit
- Positive pregnancy test
- Absence of informed consent